BAVIS_1170x120_1-20

Westport Pharmaceuticals

Perrigo licenses meth-resistant tech for PSE products

Perrigo licenses meth-resistant tech for PSE products

DUBLIN, Ireland — Perrigo Co. plc is bringing in methamphetamine-blocking capability for pseudoephedrine (PSE) products. On Tuesday, Perrigo said it has entered an exclusive licensing agreement with St. Louis-based Highland Pharmaceuticals for its Tarex meth-blocking technology. The deal also includes the distribution rights of Zephrex-D, the pseudoephedrine nasal decongestant marketed by Highland’s Westport Pharmaceuticals unit.

New mission for retired military dogs

ST. LOUIS — Five retired military dogs that spent years working in war zones are putting their noses to new uses by helping police in the U.S. combat methamphetamine and other drugs, thanks in part to financial support from Westport Pharmaceuticals. The animals are being deployed to police departments in Indiana, Texas, Tennessee, Nebraska and